With Trump’s signature on the Farm Bill, hemp gains federally legal status

December 20, 2018

President Donald Trump has signed hemp legalization into law, a change expected to unleash seismic market changes for the hemp industry.

Trump’s signature on the 2018 Farm Bill immediately removes hemp – defined cannabis below 0.3% THC – from the Controlled Substances Act.

Hemp legalization passes House; Farm Bill heads to Trump for final approval

December 12, 2018

Nationwide hemp legalization cleared its final congressional hurdle Wednesday, sending the watershed 2018 Farm Bill that removes hemp from the Controlled Substances Act to President Donald Trump.

The House voted 369-47 to pass a Farm Bill compromise that includes legalizing cannabis plants with no more than 0.3% THC.

No extraction required: Smokable hemp trend gives farmers new use for flower

November 19, 2018

One of the fastest-growing hemp sectors bears a striking resemblance to the marijuana industry: dried and smokable hemp flowers.

The growth of hemp pre-rolls and loose flower has roots in Europe, where cannabis enthusiasts have long embraced smoking low-THC cannabis, but its rise in the U.S. is catching longtime hemp industry watchers by surprise.

Sales begin for first FDA-approved CBD drug

November 02, 2018

Sales are underway for the first CBD drug approved by the U.S. Food and Drug Administration.

The drug, Epidiolex, treats two rare types of epilepsy and is made from marijuana plants grown in the United Kingdom.

Academia joins CBD research boom, offering new market opportunities

October 26, 2018

Lack of significant research on the effect of cannabinoids has long been a bane to the CBD and hemp industries. But in the wake of the U.S. Drug Enforcement Administration’s decision to reschedule some cannabis-derived products, researchers are looking for ways to open and capitalize on new markets and uses.

Walmart Canada ‘fact-finding’ on potential for CBD product sales

October 11, 2018

The world’s largest retailer, Walmart, is considering selling CBD products in Canada, a development that comes just days before recreational marijuana markets open in the country.

DEA takes some CBD off Schedule 1 – with FDA approval

September 27, 2018

The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.


The agency announced Thursday that drugs including “finished dosage formulations” of CBD with THC below 0.1% will be considered Schedule 5 drugs, as long as the medications have been approved by the U.S. Food and Drug Administration.

Capitalizing on the CBD Surge

September 09, 2018

Demand for THC's nonintoxicating cousin is booming, but a shifting legal landscape and excess supply of CBD products present potential pitfalls.

Coca-Cola eyes CBD ‘functional wellness beverages’ as soda market cools

September 17, 2018

The Coca-Cola Co., the world’s largest beverage maker, is looking at a line of CBD beverages, the company confirmed Monday.

“Along with many others in the beverage industry, we are closely watching the growth of nonpsychoactive CBD as an ingredient in functional wellness beverages around the world,” Coca-Cola spokesman Kent Landers said in a statement.

Congress Finally Can Tell Hemp From Pot

August 07, 2018

For almost 50 years, hemp has been lumped together with heroin, LSD, and Ecstasy, but new legislation could soon make the crop legal for farmers still struggling from the loss of tobacco.

GW Pharmaceuticals Slaps Price Tag on Cannabis-Based Epilepsy Drug

August 09, 2018

GW Pharmaceuticals has finally revealed the price of its cannabis-based epilepsy drug Epidiolex. The medication, which is expected to be available by early fall, will have a $32,500 price tag.


July 24, 2018

Houston, TX — RVHarvest LLC, an investment vehicle to fund the farming of specialized hemp for the cannabinoid-rich industrial hemp oil market, announced they are opening a funding round for the 2019 Hemp CBD season at

‘Open up the floodgates’: FDA approval signals further CBD investment

July 05, 2018

Federal approval for a CBD drug means more for the hemp industry than just validation that cannabidiol has medical value.

It’s also expected to increase investment in pharmaceutical uses for CBD derived from either hemp or marijuana, according to business owners working on other medicines extracted from the cannabis plant.

Rise of CBD raises concerns for marijuana executives

June 28, 2018

That growing mainstream appeal has some cannabis business owners concerned that CBD is a threat to the THC-reliant marijuana market.

According to cannabis research firm Brightfield Group, the CBD market could be worth more than $2 billion a year by 2021.  Two-thirds of that CBD would come from hemp, not marijuana, the company projects.

U.S. Senate Votes To Legalize Hemp After Decades-Long Ban Under Marijuana Prohibition

June 28, 2018

U.S. Senate Votes To Legalize Hemp After Decades-Long Ban Under Marijuana Prohibition

Please reload

DISCLAIMER: RVHarvest LLC is in the process of evaluating investment opportunities. This website is not an advertisement, offer or solicitation for investment. The content contained within is meant only to help investors determine if they potentially meet the "Accredited Investor" qualifications set forth by the SEC. Should you be interested in learning more about RVHarvest LLC please contact us to receive more information by clicking the blue button below.

Todd Brinegar
Contact Us:
p: 281-685-6004
  • Facebook Social Icon